Brainstem mechanisms of autonomic dysfunction in encephalopathy-associated Shiga toxin 2 intoxication
Corresponding Author
Yoji Yamada MD
Department of Urology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Department of Urology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu 807-8555, JapanSearch for more papers by this authorJun Fujii MD, PhD
Department of Microbiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorYoshinobu Murasato MD, PhD
Department of Systems Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorTadashi Nakamura MD, PhD
Department of Systems Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorYoshiaki Hayashida MD, PhD
Department of Systems Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorYoshimasa Kinoshita MD, PhD
Department of Neurosurgery, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorTetsuro Matsumoto MD, PhD
Department of Urology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorShin-Ichi Yoshida MD, PhD
Department of Microbiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorCorresponding Author
Yoji Yamada MD
Department of Urology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Department of Urology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu 807-8555, JapanSearch for more papers by this authorJun Fujii MD, PhD
Department of Microbiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorYoshinobu Murasato MD, PhD
Department of Systems Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorTadashi Nakamura MD, PhD
Department of Systems Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorYoshiaki Hayashida MD, PhD
Department of Systems Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorYoshimasa Kinoshita MD, PhD
Department of Neurosurgery, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorTetsuro Matsumoto MD, PhD
Department of Urology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorShin-Ichi Yoshida MD, PhD
Department of Microbiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
Search for more papers by this authorAbstract
Acute encephalopathy is the major determinant of death in an early stage of Shiga toxin (Stx)-producing Escherichia coli infection. Rapid progress toward refractory hypotension and dysfunction of breathing implies autonomic center dysfunction of patients. To clarify whether autonomic dysfunction becomes an ultimate cause of death in Shiga toxemia, we injected purified Stx2 (20 μg/kg) intravenously into rabbits, and monitored changes in cardiovascular and respiratory function together with renal sympathetic nerve activity (RSNA) in the conscious state. After an approximately 24-hour silent (lag) period, all rabbits given Stx2 developed hemorrhagic diarrhea (25.7 ± 1.1 hours) and limb paralysis (31.2 ± 1.3 hours). This limb paralysis was observed initially in the hind legs, and then it gradually extended to the forelegs. After 23.2 ± 2.3 hours, RSNA increased gradually, and arterial blood pressure was maintained within normal limits together with an increase in the maximum gain of baroreflex response. Severe hypotension developed within 34.8 ± 2.2 hours, without any increase in heart rate; RSNA significantly increased by 39.5 ± 0.9 hours. In the final stage, RSNA decreased concurrently with decreases in arterial blood pressure, heart rate, and baroreflex response, suggesting dysfunction of the baroreflex control system. Thereafter, all rabbits died within 47.8 ± 1.2 hours after the intravenous Stx2 injection. Magnetic resonance imagings of the central nervous system (T2-weighted images) showed high-intensity areas in the dorsal two-thirds of the cervical spinal cord and brainstem 48 hours after Stx2 administration. These results show that the cause of death is circulatory failure caused by impairment of the cardiovascular center in the medulla. We believe that this animal model helps to clarify the mechanism of rapid progress to death of patients with Shiga toxin–producing E coli infection. Ann Neurol 1999;45:716–723
References
- 1 Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308: 681–685
- 2 Karmali MA, Petric M, Lim C, et al. The association between idiopathic hemolytic-uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151: 775–782
- 3 Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2: 15–38
- 4 Hamano S, Nakanishi Y, Nara T, et al. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Pediatr 1991; 82: 454–458
- 5 Rooney JC, Anderson RM, Hopkins IJ. Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome. Aust Pediatr J 1971; 7: 28–33
- 6 Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994; 94: 35–40
- 7 Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic uremic syndrome. J Pediatr 1994; 125: 511–518
- 8 Tzipori S, Chow CW, Powell HR. Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J Clin Pathol 1988; 41: 1099–1103
- 9 Upadhyaya K, Barwick K, Fishaut M, et al. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 1980; 65: 115–120
- 10 Francis DH, Moxley RA, Andraos CY. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect Immun 1989; 57: 1339–1342
- 11 Robson WL, Leung AK, Montgomery MD. Causes of death in hemolytic uremic syndrome. Child Nephrol Urol 1991; 11: 228–233
- 12 Bos AP, Donckerwolcke RA, van Vught AJ. The hemolytic-uremic syndrome: prognostic significance of neurological abnormalities. Helv Paediatr Acta 1985; 40: 381–389
- 13 Sanada M, Okano H, Yokota S, et al. Electrocardiographic study of sinus bradycardia associated with enterohemorrhagic Escherichia coli O157:H7 infection [in Japanese]. Kokyu To Junkan 1993; 41: 653–657
- 14 Fujii J, Kita T, Yoshida S, et al. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun 1994; 62: 3447–3453
- 15 Barrett TJ, Potter ME, Wachsmuth IK. Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT-II-induced disease. J Infect Dis 1989; 159: 774–777
- 16 Bridgwater FAJ, Morgan RS, Rowson KEK, Wright GP. The neurotoxin of Shigella shigae: morphological and functional lesions produced in the central nervous system of rabbits. Br J Exp Pathol 1955; 36: 447–453
- 17 Fujii J, Kinoshita Y, Kita T, et al. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun 1996; 64: 5053–5060
- 18 Mizuguchi M, Tanaka S, Fujii I, et al. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Acta Neuropathol 1996; 91: 254–262
- 19 Richardson SE, Rotman TA, Jay V, et al. Experimental verocytotoxemia in rabbits. Infect Immun 1992; 60: 4154–4167
- 20 Zoja C, Corna D, Farina C, et al. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med 1992; 120: 229–238
- 21 Lingwood CA. Role of verotoxin receptors in pathogenesis. Trends Microbiol 1996; 4: 147–153
- 22 Lord JM, Roberts LM, Robertus JD. Ricin: structure, mode of action, and some current applications. Fed Am Soc Exp Biol J 1994; 8: 201–208
- 23 Christiansen VJ, Hsu CH, Dormer KJ, Robinson CP. The cardiovascular effects of ricin in rabbits. Pharmacol Toxicol 1994; 74: 148–152
- 24 Ma L, Hsu CH, Patterson E, et al. Ricin depresses cardiac function in the rabbit heart. Toxicol Appl Pharmacol 1996; 138: 72–76
- 25 Christiansen VJ, Hsu CH, Zhang L, Robinson CP. Effects of ricin on the ability of rabbit arteries to contract and relax. J Appl Toxicol 1995; 15: 37–43
- 26 Zhou ZZ, Wurster RD, Jones SB. Arterial baroreflexes are not essential in mediating sympathoadrenal activation in conscious endotoxic rats. J Auton Nerv Syst 1992; 39: 1–12
- 27 Hirakawa H, Nakamura T, Hayashida Y. Effect of carbon dioxide on autonomic cardiovascular responses to systemic hypoxia in conscious rats. Am J Physiol 1997; 273: 747–754
- 28 Kent BB, Drane JW, Blumenstein B, Manning JW. A mathematical model to assess changes in the baroreceptor reflex. Cardiology 1972; 57: 295–310
- 29 Nakamura T, Hayashida Y. Autonomic cardiovascular responses to smoke exposure in conscious rats. Am J Physiol 1992; 262: 738–745
- 30 Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y. Purification and some properties of a vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog 1987; 3: 21–30
- 31 Nohta H, Mitsui A, Ohkura Y. Spectrofluorimetric determination of catecholamines with 1,2-diphenylethylenediamine. Anal Chim Acta 1984; 165: 171–176
- 32 Sugimoto N, Haque A, Horiguchi Y, Matsuda M. Coronary vasoconstriction is the most probable cause of death of rats intoxicated with botulinolysin, a hemolysin produced by Clostridium botulinum. Toxicon 1995; 33: 1215–1230
- 33 Sakurai J, Oshita Y, Fujii Y. Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats. Toxicon 1985; 23: 903–912
- 34 Asmuth DM, Olson RD, Hackett SP, et al. Effects of Clostridium perfringens recombinant and crude phospholipase C and θ-toxin on rabbit hemodynamic parameters. J Infect Dis 1995; 172: 1317–1323
- 35 Feuerstein G, Goldstein DS, Ramwell PW, et al. Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat. J Pharmacol Exp Ther 1985; 232: 786–794
- 36 Bitzan MM, Wang Y, Lin J, Marsden PA. Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ec NOS) expression and NO production in vascular endothelium. J Clin Invest 1998; 101: 372–382
- 37 Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987; 262: 8128–8130
- 38 Peterson DF, Coote JH, Gilbey MP, Futuro-Neto HA. Differential pattern of sympathetic outflow during upper airway stimulation with smoke. Am J Physiol 1983; 245: 433–437
- 39 Lin YC. Autonomic nervous control of cardiovascular response during diving in the rat. Am J Physiol 1974; 227: 601–605
- 40 Bielaszewska M, Clarke I, Karmali MA, Petric M. Localization of intravenously administered verocytotoxins (Shiga-like toxin) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect Immun 1997; 65: 2509–2516